![Mayo Clinic home page [logo]](/images-global/mayologo.gif)
Give. Touch. Transform.
Share this site with others using one of these sharing tools.
To link to this article, paste this block of HTML code onto your webpage.
Guidelines for sites linking to mayoclinic.orgOne out of three breast cancers makes an abnormal amount of a protein known as Her-2-nu. This protein helps to drive the growth of the cancer. A simple test of breast cancer cells can tell if the cancer makes this protein. If it does, a new treatment, Herceptin, is available. Herceptin is a targeted therapy that attacks this abnormal protein.
.
